Briacell Therapeutics Corp Stock Ownership - Who owns Briacell Therapeutics?

Open Broker Account

Insider buying vs selling

Have Briacell Therapeutics Corp insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BCTX insiders and whales buy or sell their stock.

BCTX Shareholders

What type of owners hold Briacell Therapeutics Corp stock?
Marc Lustig10.57%1,640,000$9.61MInsider
Kj Harrison Partners Inc10.36%1,607,027$9.42MInstitution
Lynwood Capital Management Inc3.96%615,000$3.60MInstitution
Wasatch Advisors Inc2.30%356,498$2.09MInstitution
Williams V. Williams0.96%149,636$876.87kInsider
Redmond Asset Management LLC0.89%137,942$808.34kInstitution
Jamieson Bondarenko0.77%119,856$702.36kInsider
Sabby Management LLC0.37%57,589$337.47kInstitution
Jane Street Group LLC0.32%50,284$294.66kInstitution
Summit Trail Advisors LLC0.23%35,000$205.10kInstitution

1 of 3

BCTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FIXX43.07%20.22%Net Selling
LGVN1.63%98.37%Net SellingNet Selling
SPPI31.07%6.63%Net Selling

Briacell Therapeutics Stock Ownership FAQ

Who owns Briacell Therapeutics?

Briacell Therapeutics (NASDAQ: BCTX) is owned by 19.12% institutional shareholders, 12.39% Briacell Therapeutics insiders, and 68.49% retail investors. Marc Lustig is the largest individual Briacell Therapeutics shareholder, owning 1.64M shares representing 10.57% of the company. Marc Lustig's Briacell Therapeutics shares are currently valued at $9.22M.

If you're new to stock investing, here's how to buy Briacell Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.